Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Accepted manuscripts
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Special issues
    • Subject collections
    • Cell Scientists to Watch
    • First Person
    • Sign up for alerts
  • About us
    • About JCS
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Fast-track manuscripts
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • JCS Prize
    • Manuscript transfer network
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contacts
    • Contact JCS
    • Subscriptions
    • Advertising
    • Feedback
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

User menu

  • Log in

Search

  • Advanced search
Journal of Cell Science
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

supporting biologistsinspiring biology

Journal of Cell Science

  • Log in
Advanced search

RSS   Twitter  Facebook   YouTube  

  • Home
  • Articles
    • Accepted manuscripts
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Special issues
    • Subject collections
    • Cell Scientists to Watch
    • First Person
    • Sign up for alerts
  • About us
    • About JCS
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Fast-track manuscripts
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • JCS Prize
    • Manuscript transfer network
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contacts
    • Contact JCS
    • Subscriptions
    • Advertising
    • Feedback
Research Article
Wnt signalling in osteoblasts regulates expression of the receptor activator of NFκB ligand and inhibits osteoclastogenesis in vitro
Gary J. Spencer, Jennifer C. Utting, Sharon L. Etheridge, Timothy R. Arnett, Paul G. Genever
Journal of Cell Science 2006 119: 1283-1296; doi: 10.1242/jcs.02883
Gary J. Spencer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer C. Utting
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharon L. Etheridge
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy R. Arnett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul G. Genever
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & tables
  • Supp info
  • Info & metrics
  • PDF + SI
  • PDF
Loading

Article Figures & Tables

Figures

  •   Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    RT-PCR analysis of Wnt signalling components in osteoblastic cells. (A) Secreted Wnt ligands, (B) Frizzled receptors (FZD), (C) secreted frizzled related peptides (SFRPs), (D) intracellular signalling components, (E) transcriptional machinery and (F) TCF/LEF transcription factors.

  •   Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Nuclear translocation of β-catenin in osteoblasts. (A) Wnt3a-conditioned medium (Wnt3a) stimulated β-catenin translocation in MC3T3-E1 cells (arrows) compared with cells incubated with control conditioned medium (L-cells). Bar, 5 μm. (B) Dose-dependence of Wnt3a induced β-catenin translocation in MC3T3-E1 cells. No effect was observed in cells exposed to L-cell conditioned medium at all concentrations tested. (C) Dkk-1 inhibited the nuclear accumulation of β-catenin induced by 25% Wnt3a in MC3T3-E1 cells (mean ± s.e.m., n=12; **P<0.01, ***P<0.001; n.s., not significant).

  •   Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Mimicking Wnt signalling in osteoblasts stimulates β-catenin nuclear translocation and TCF/LEF-dependent transcriptional activation. (A) Inhibition of GSK3β with LiCl (20 mM) stimulated β-catenin nuclear translocation in SaOS-2 cells (arrows) compared with NaCl controls. Bar, 5 μm. (B) Inhibition of GSK3β with LiCl (20 mM) stimulated TOPFLASH TCF/LEF gene transcription in SaOS-2 cells compared with cells incubated with vehicle alone or those transfected with control reporter containing mutant TCF/LEF binding sites (FOPFLASH). Mean values are shown ± s.d., n=4. (C) Time course of LiCl-stimulated gene transcription in MG-63 cells. LiCl stimulated TCF/LEF reporter gene transcription from 5 hours post treatment (mean ± s.e.m., n=8; ***P≤0.001).

  •   Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    β-catenin transactivates TCF/LEF gene transcription in osteoblasts. (A) Overexpression of β-catenin EGFP fusion protein significantly increased TCF/LEF-dependent transcription of a luciferase reporter gene (TOPFLASH) in MG-63 cells compared with cells transfected with control reporter containing mutant TCF/LEF binding sites (FOPFLASH). By contrast, overexpression of a β-catenin C-terminal mutant lacking the transactivation domain (β-catenin ΔC695-781) failed to activate transcription (values are mean ± s.d., n=4; ***P≤0.001; n.s., not significant). (B) Both full-length β-catenin and β-catenin ΔC localised to the nucleus of osteoblasts (arrows). EGFP, Green; DAPI, blue. Bar, 10 μm.

  •   Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    (A) Schematic representation of the human RANKL promoter illustrating putative TCF/LEF transcription factor binding sites. MattInspector software was used to examine the human RANKL promoter (GenBank accession number AF333234) for the presence of the consensus TCF/LEF binding sequence ctttgww. Relative positions and nucleotide sequences of putative binding sites are shown (a-d: a, ctttgaa; b, ttcaaag; c, ctttgat; d, ctttgta). Positions indicated are relative to the translational start codon of the RANKL mRNA. Functional vitamin D3 response elements (VDRE) are shown for comparison (Kitazawa et al., 2003). (B) Mimicking Wnt signalling in osteoblasts inhibited expression of receptor activator of NFκB ligand (RANKL). Inhibition of GSK3β with LiCl (20 mM) potently inhibited RANKL mRNA expression by MC3T3-E1 cells and protein expression by MG-63 osteoblastic cells compared with the NaCl control. (C) RT-PCR analysis illustrating the inhibitory effects of recombinant Wnt on RANKL mRNA expression by MC3T3-E1 cells. Exposure to Wnt3a (100 ng/ml) inhibited expression at levels comparable with LiCl (20 mM). Expression was unaffected by treatment with recombinant Wnt5a (500 ng/ml). (D) Overexpression of full-length β-catenin inhibited basal activity of the RANKL promoter in ST2 stromal cells. Inhibitory effects were dependent on the C-terminal transactivation domain of β-catenin deleted in β-catenin ΔC695-781. Values are mean ± s.e.m., n=8; ***P≤0.001; n.s., not significant.

  •   Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Wnt signalling inhibits osteoclastogenesis in mouse primary osteoblast/mononuclear spleen cell co-cultures. (A) Inhibition of GSK3β with LiCl (5-20 mM) inhibited the formation of TRAP-positive multinucleated cells compared with cells incubated with NaCl (5-20 mM) over 12 days in culture. (B) LiCl inhibited mononuclear cell fusion (arrows indicate characteristic cell fusion in control cultures; open circles, mononuclear cells; dashed arrow, rare fused cell in LiCl-treated cultures). TRAP stained osteoclasts predominate in NaCl-treated cultures but are absent in LiCl treated cultures. DIC, digital interference contrast. (C) Wnt3a conditioned medium (Wnt3a) inhibited the formation of TRAP-positive multi-nucleated cells compared with cells incubated with control conditioned medium (L-Cell) over 12 days in culture. Values are mean ± s.e.m., n=5; ***P≤0.001; n.s., not significant.

  •   Fig. 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 7.

    Expression of LRP5 and LRP6 Wnt co-receptors by osteoblasts, osteoclast progenitors and mature osteoclasts. (A) RT-PCR demonstrating expression of LRP5 and LRP6 using cDNA generated from human osteoblastic cells (MG-63, SaOS-2 and TE85), primary human osteoblasts (HOB), mouse spleen and mature osteoclasts derived from human long-term bone marrow cultures. (B) Histogram illustrating the purity of CD14+ cells determined by flow cytometry following isolation from the mononuclear (MNC) fraction of human peripheral blood by magnetic activated cell sorting. RT-PCR demonstrating expression of LRP5 and LRP6 by CD14- (depleted) and CD14+ (enriched) cells is shown on the right. The PCR product obtained using SaOS-2 cDNA is shown for comparison.

  •   Fig. 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 8.

    Effects of Wnt signalling on human osteoclast formation and activity. Wnt3a (10-100 ng/ml) had no effect on the formation of TRAP-positive multinucleated osteoclasts generated from peripheral blood mononuclear cells cultured in the presence of RANKL and M-CSF (open bars) and had no effect on their resorptive activity (closed bars). Data are mean ± s.e.m., n=5.

  •   Fig. 9.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 9.

    Evidence for endogenous Wnt signalling in mature osteoclasts. Fluorescent immunolocalisation of β-catenin in mature disaggregated rat osteoclasts. β-catenin predominately localised to nuclei with some peripheral staining (green). Multinucleation is disclosed by DAPI (blue) and peripheral actin ring formation, typical of active bone resorbing osteoclasts is stained with Rhodamine-phalloidin (red). Bar, 10 μm.

  •   Fig. 10.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 10.

    Effects of recombinant Wnt3a on the survival and activity of mature osteoclasts. Osteoclasts were generated from peripheral blood mononuclear cells cultured in the presence of RANKL and M-CSF for 14 days, and treated with recombinant Wnt3a (50 ng/ml) or vehicle alone for the final 48 hours of culture. The number of TRAP-positive osteoclasts and the area of bone resorption were quantified. Wnt3a had no reproducible effect on osteoclast survival or their resorptive activity. Data are mean ± s.e.m., n=5.

Previous ArticleNext Article
Back to top
Previous ArticleNext Article

This Issue

 Download PDF

Email

Thank you for your interest in spreading the word on Journal of Cell Science.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Wnt signalling in osteoblasts regulates expression of the receptor activator of NFκB ligand and inhibits osteoclastogenesis in vitro
(Your Name) has sent you a message from Journal of Cell Science
(Your Name) thought you would like to see the Journal of Cell Science web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Research Article
Wnt signalling in osteoblasts regulates expression of the receptor activator of NFκB ligand and inhibits osteoclastogenesis in vitro
Gary J. Spencer, Jennifer C. Utting, Sharon L. Etheridge, Timothy R. Arnett, Paul G. Genever
Journal of Cell Science 2006 119: 1283-1296; doi: 10.1242/jcs.02883
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Research Article
Wnt signalling in osteoblasts regulates expression of the receptor activator of NFκB ligand and inhibits osteoclastogenesis in vitro
Gary J. Spencer, Jennifer C. Utting, Sharon L. Etheridge, Timothy R. Arnett, Paul G. Genever
Journal of Cell Science 2006 119: 1283-1296; doi: 10.1242/jcs.02883

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Alerts

Please log in to add an alert for this article.

Sign in to email alerts with your email address

Article navigation

  • Top
  • Article
    • Summary
    • Introduction
    • Results
    • Discussion
    • Materials and Methods
    • Acknowledgments
    • Footnotes
    • References
  • Figures & tables
  • Supp info
  • Info & metrics
  • PDF + SI
  • PDF

Related articles

Cited by...

More in this TOC section

  • Histone chaperone APLF level dictates the implantation of mouse embryos
  • Switching between blebbing and lamellipodia depends on the degree of non-muscle myosin II activity
  • Kindlin-2 promotes rear focal adhesion disassembly and directional persistence during cell migration
Show more RESEARCH ARTICLE

Similar articles

Other journals from The Company of Biologists

Development

Journal of Experimental Biology

Disease Models & Mechanisms

Biology Open

Advertisement

2020 at The Company of Biologists

Despite the challenges of 2020, we were able to bring a number of long-term projects and new ventures to fruition. While we look forward to a new year, join us as we reflect on the triumphs of the last 12 months.


Mole – The Corona Files

"This is not going to go away, 'like a miracle.' We have to do magic. And I know we can."

Mole continues to offer his wise words to researchers on how to manage during the COVID-19 pandemic.


Cell scientist to watch – Christine Faulkner

In an interview, Christine Faulkner talks about where her interest in plant science began, how she found the transition between Australia and the UK, and shares her thoughts on virtual conferences.


Read & Publish participation extends worldwide

“The clear advantages are rapid and efficient exposure and easy access to my article around the world. I believe it is great to have this publishing option in fast-growing fields in biomedical research.”

Dr Jaceques Behmoaras (Imperial College London) shares his experience of publishing Open Access as part of our growing Read & Publish initiative. We now have over 60 institutions in 12 countries taking part – find out more and view our full list of participating institutions.


JCS and COVID-19

For more information on measures Journal of Cell Science is taking to support the community during the COVID-19 pandemic, please see here.

If you have any questions or concerns, please do not hestiate to contact the Editorial Office.

Articles

  • Accepted manuscripts
  • Latest complete issue
  • Issue archive
  • Archive by article type
  • Special issues
  • Subject collections
  • Interviews
  • Sign up for alerts

About us

  • About Journal of Cell Science
  • Editors and Board
  • Editor biographies
  • Travelling Fellowships
  • Grants and funding
  • Journal Meetings
  • Workshops
  • The Company of Biologists

For Authors

  • Submit a manuscript
  • Aims and scope
  • Presubmission enquiries
  • Fast-track manuscripts
  • Article types
  • Manuscript preparation
  • Cover suggestions
  • Editorial process
  • Promoting your paper
  • Open Access
  • JCS Prize
  • Manuscript transfer network
  • Biology Open transfer

Journal Info

  • Journal policies
  • Rights and permissions
  • Media policies
  • Reviewer guide
  • Sign up for alerts

Contacts

  • Contact JCS
  • Subscriptions
  • Advertising
  • Feedback

Twitter   YouTube   LinkedIn

© 2021   The Company of Biologists Ltd   Registered Charity 277992